<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-5696</issn><issn publication-format="electronic">2079-5831</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">28507</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Results of the study of HPV-typing of anogenital area in patients with cervical intraepithelial neoplasia</article-title><trans-title-group xml:lang="ru"><trans-title>Результаты ВПЧ-генотипирования эпителия шейки матки и анальной области у пациенток с цервикальными интраэпителиальными неоплазиями</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sulamanidze</surname><given-names>L A</given-names></name><name xml:lang="ru"><surname>Суламанидзе</surname><given-names>Лика Автандиловна</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>lika.sulamanidze@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Nazarova</surname><given-names>N M</given-names></name><name xml:lang="ru"><surname>Назарова</surname><given-names>Нисо Мирзоевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, вед. науч. сотр. научно- поликлинического отд-ния ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>grab2@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Prilepskaya</surname><given-names>V N</given-names></name><name xml:lang="ru"><surname>Прилепская</surname><given-names>Вера Николаевна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, проф., зам. дир., рук. научно- поликлинического отд-ния ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>VPrilepskaya@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Burmenskaya</surname><given-names>O V</given-names></name><name xml:lang="ru"><surname>Бурменская</surname><given-names>Ольга Владимировна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р биол. наук, науч. сотр. лаб. молекулярно-генетических методов ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>o_bourmenskaya@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Demura</surname><given-names>T A</given-names></name><name xml:lang="ru"><surname>Демура</surname><given-names>Татьяна Александровна</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, ст. науч. сотр. 1-го патологоанатомического отд-ния ФГБУ НЦАГиП им. акад. В.И. Кулакова</p></bio><email>demura-t@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gordeev</surname><given-names>S S</given-names></name><name xml:lang="ru"><surname>Гордеев</surname><given-names>Сергей Сергеевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, хирург-онколог хирургического отд- ния №3 ФГБНУ РОНЦ им. Н.Н.Блохина</p></bio><email>ss.netoncology@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chuprynin</surname><given-names>V D</given-names></name><name xml:lang="ru"><surname>Чупрынин</surname><given-names>Владимир Дмитриевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>канд. мед. наук, рук. хирургического отд-ния ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>v_chuprynin@oparina4.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Trofimov</surname><given-names>D Yu</given-names></name><name xml:lang="ru"><surname>Трофимов</surname><given-names>Дмитрий Юрьевич</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р биол. наук, зав. лаб. молекулярно- генетических методов ФГБУ НЦАГиП им. акад. В.И.Кулакова</p></bio><email>d.trofimov@dna-tech.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">V.I.Kulakov Research Center for Obstetrics, Gynecology and Perinatology of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N.N.Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБНУ Российский онкологический научный центр им. Н.Н.Блохина</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2016</year></pub-date><volume>18</volume><issue>1</issue><issue-title xml:lang="en">VOL 18, NO1 (2016)</issue-title><issue-title xml:lang="ru">ТОМ 18, №1 (2016)</issue-title><fpage>45</fpage><lpage>48</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2016, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2016, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://gynecology.orscience.ru/2079-5831/article/view/28507">https://gynecology.orscience.ru/2079-5831/article/view/28507</self-uri><abstract xml:lang="en"><p>Objective: to study the prevalence of different types of human papilloma virus (HPV) in cervix and anal canal in patients with HPV-associated cervical intraepithelial neoplasia (CIN) of varying severity.Material and methods: the clinical examination, colposcopy; high resolution anoscopy; cytology; typing of HPV.Results. The study involved 204 women, mean age 30±1.2 years. By results of inspection are formed 2 groups: 1 - 92 (45%) with CIN I-III, 2 - 112 (55%) without CIN. In group 1 in the cervical canal were detected HPV 16, 68 (р&lt;0.05), in anal region 15, 56 (р&lt;0.05). In group 2 in the cervical canal were detected HPV 16 (21.4%), 52(19.6%), 31, 44 (12.5%), 33 (10.7%), in anal region 44 (25%), 31 (19.4%), 53, 6(13.8%), 16, 52, 11, 18 (11.1%). In patients in group 1, 1.5 times more likely was found changes of anal epithelium compared with the group 2. Abnormal anal cytology was found in 12% of patients. High risk HPV cause more severe changes in the anal epithelium similar to the cervix.Conclusion. In patients with HPV-associated diseases of anogenital region revealed differences in the types of HPV in the cervical canal and anal region. The dominant type of HPV in women with CIN in the cervix and anus is the HPV type 16. HPV-associated cervical disease, including CIN, pose a risk of infection and HPV-associated diseases of the anal region, including anal intraepithelial neoplasia.</p></abstract><trans-abstract xml:lang="ru"><p>Цель работы - изучить частоту встречаемости различных типов вируса папилломы человека (ВПЧ) в цервикальном канале и анальной области у пациенток с ВПЧ-ассоциированными цервикальными интраэпителиальными неоплазиями (CIN) разной степени тяжести и сравнить с результатами аноскопии с высоким разрешением и анальной цитологии.Материал и методы: клинические методы исследования; расширенная кольпоскопия; аноскопия с высоким разрешением; цитологический метод; типирование ВПЧ.Результаты. Обследованы 204 женщины, средний возраст 30±1,2 года. По результатам обследования сформировано 2 группы: 1-я - 92 (45%) женщины с гистологически верифицированным диагнозом CIN I-III, 2-я - 112 (55%) без CIN. У пациенток 1-й группы в цервикальном канале достоверно чаще встречались ВПЧ 16, 68-го типа, при этом в анальной области - 15, 56-го типа (р&lt;0,05). У женщин 2- й группы в цервикальном канале наиболее часто встречались 16 (21,4%), 52 (19,6%), 31, 44 (12,5%), 33-й тип (10,7%). В анальной области наиболее частовстречались 44 (25%), 31 (19,4%), 53, 6 (13,8%), 16, 52, 11, 18-й тип (11,1%). Упациенток 1-й группы в 1,5 раза чаще выявлялись выраженные и слабовыраженные изменения анального эпителия по сравнению со 2-й группой. Аномальная анальная цитология была выявлена у 12% пациенток.Высокоонкогенные типы ВПЧ вызывают более тяжелые изменения анального эпителия по аналогии с шейкой матки.Заключение. У пациенток с CIN выявлены различия типов ВПЧ в цервикальном канале и анальной области. Доминирующим типом ВПЧ у пациенток с CIN в цервикальном канале и анусе является ВПЧ 16-го типа. ВПЧ-ассоциированные заболевания шейки матки, в частности CIN, создают риск инфицирования и развития ВПЧ-ассоциированных заболеваний анальной области, в том числе и анальной интраэпителиальной неоплазии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>cervical intraepithelial neoplasia</kwd><kwd>human papilloma virus</kwd><kwd>cervical cancer</kwd><kwd>anal intraepithelial neoplasia</kwd><kwd>high resolution anoscopy</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>цервикальная интраэпителиальная неоплазия</kwd><kwd>вирус папилломы человека</kwd><kwd>рак шейки матки</kwd><kwd>анальная интраэпителиальная неоплазия</kwd><kwd>аноскопия с высоким разрешением</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Centers for Disease Control and Prevention. Incidence, Prevalence, and Cost of Sexually Transmitted Infections in the United States, February 2013.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Comparetto C, Borruto F. Human Papillomavirus Infection: Overview. Handbook on human papillomavirus: prevalence, detection and management (Harris B.Smith). New York: Nova Science Publishers, Inc. 2013; 1: 1-137.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Schiffman M, Wentzensen N. From Human papillomavirus to cervical cancer. Obstet Gynecol 2010; 116 (1): 177-85.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bosh F.X, Manos M.M, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Walboomers J.M, Jacobs M.V, Manos M.M et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 87: 796-802.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>De Sanjose S, Quint W.G, Alemany L et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross - sectional worldwide study. Lancet Oncol 2010; 11: 1048.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Bosh F.X, Lorincz A, Munoz N et al. The causal realation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Shiffman M, Kjaer S.K. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. Vaccine 2008; 26 (Suppl. 10): K1-16.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-key-statistics</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Scholefield J.H, Castle M.T, Watson N.F. Malignant transformation of high - grade anal intraepithelial neoplasia. Br J Surg 2005; 92: 1133-6.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>http://www.cancer.org/cancer/analcancer/detailedguide/anal-cancer-what-is-key-statistics</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Johnson L.G, Madeleine M.M, Newcomer L.M et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004; 101 (2): 281-8.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Прилепская В.Н., Назарова Н.М., Суламанидзе Л.А. и др. Взаимосвязь ВПЧ-ассоциированных неоплазий генитальной и анальной областей, их диагностики и лечения. Акушерство и гинекология. 2014; 1: 23-8.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>El-Naggar A.C, Santoso J.T. MD Risk Factors for Anal Intraepithelial Neoplasia in Women With Genital Dysplasia. Obstet Gynecol 2013; 122 (2): 1.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Суламанидзе Л.А., Назарова Н.М., Бурменская О.В. и др. Распространенность анальной ВПЧ-инфекции у женщин с цервикальными неоплазиями. XXI Всероссийский конгресс с международным участием «Амбулаторно - поликлиническая помощь: от менархе до менопаузы». 3-6 марта, 2015. Сборник тезисов. С. 153-4.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Berry J.M, Jay N, Palefsky J.M. The anal canal and perianus: HPV-related disease. Modern coploscopy textbook and atlas (E.J.Mayeaux Jr, MD, J.Thomas Cox, MD). ASCCP 2013; 17: 488.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Quaas J, Reich O, Frey Tirri B, Küppers V. Explanation and Use of the Colposcopy Terminology of the IFCPC (International Federation for Cervical Pathology and Colposcopy Rio 2011). 2013.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Darragh T.M, Birdsong G.G, Luff R.D, Davey D.D. Anal - rectal cytology. In: Solomon D, Nayar R, eds. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria and Explanatory Notes (2nd ed.). New York: Springer, 2004: 169-75.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Darragh T.M. Anal cytology. In: Wilbur D.C, Henry M.R, eds. College of American Pathologists Practical Guide to Gynecologic Cytopathology: Morphology, Management and Molecular Methods. Northfield, IL: CAP Press, 2008; p. 177-81.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Edgren G, Sparén P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective populationbased study. Lancet Oncol 2007; 8: 311-6.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Palefsky J.M, Holly E.A, Ralston M.L et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high - risk HIV-negative women. J Infect Dis 2001; 183: 383-91.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Tandon R, Baranoski A.S, Huang F et al. Abnormal anal cytology in HIV-infected women. Am J Obstet Gynecol 2010; 203 (21): e21-6.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Durante A.J, Williams A.B, Da Costa M et al. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virusinfected women. Cancer Epidemiol Biomarkers Prev 2003; 12: 638-42.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Hessol N.A, Holly E.A, Efird J.T et al. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high - risk HIV-uninfected women. AIDS 2009; 23: 59-70.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Kojic E.M, Cu-Uvin S, Conley L et al. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIVinfected women in the Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (The SUN Study). Sex Transm Dis 2011; 38: 253-9.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Baranoski A.S, Tandon R, Weinberg J et al. Risk factors for abnormal anal cytology over time in HIV-infected women. Am J Obstet Gynecol 2012; 207 (107): e1-8.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Goncalves M.A, Randi G, Arslan A et al. HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer 2008; 3: 5.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Jay N, Berry J.M, Miaskowski C et al. Colposcopic characteristics and Lugol'sstaining differentiate anal high - grade and low - grade squamous intraepithelial lesions during high resolution anoscopy. Papillomavirus Res 2015.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Saleem A.M, Paulus J.K, Shapter A.P et al. Risk of anal cancer in a cohort with human papillomavirusrelated gynecologic neoplasm. Obstet Gynecol 2011; 117: 643-9.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Benard V.B, Johnson C.J, Thompson T.D et al. Examining the association between socioeconomic status and potential human papillomavirus - associated cancers. Cancer 2008; 113 (Suppl. 10): 2910-8.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Fisher G, Harlow S.D, Schottenfeld D. Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985-1992. Gynecol Oncol 1997; 64: 213-23.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Frisch M, Goodman M.T. Human papillomavirus - associated anal carcinbomas in Hawaii and the mainland US. Cancer 2000; 88: 1464-9.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Joseph D.A, Miller J.W, Wu X et al. Understanding the burden of human papillomavirus associated anal cancers in the US. Cancer 2008; 113 (Suppl. 10): 2892-900.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Nelson R.A, Levine A.M, Bernstein L et al. Changing patterns of anal carcinoma in the United States. J Clin Oncol 2013; 31: 1569-75.</mixed-citation></ref></ref-list></back></article>
